Low Signal

AC [Adriamycin (A) (also known as doxorubicin) and Cyclophosphamide (C)] Followed By Paclitaxel (P)

AC [Adriamycin (A) (also known as doxorubicin) and Cyclophosphamide (C)] Followed By Paclitaxel (P) is flagged as low signal because public records show limited public risk signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Breast Cancer

Mechanism: Unknown

Modality: Unknown

Sponsor: Memorial Sloan Kettering Cancer Center

Scores

Risk-signal summary

Registry: 0/5

Timeline: 1/5

Recruitment burden: 0/5

Results availability: 0/5

Program risk: 0/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT00591851

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT00591851Low Signal (COMPLETED)stale_update_signalLow SignalNone